Brief: ODI Pharma Q3 Pretax Loss At SEK 1.7 Mln
28/05/2020 14:49
May 28 (Reuters) - Odi Pharma AB (publ) ODI.TE :
* Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -1 662 333
Source text for Eikon: ID:nWkr4Pd3wY
Further company coverage: ODI.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Odi Pharma AB (publ)
See all newsBrief: Odi Pharma Proposes Directed Share Issue Of Approximately Sek 2.0 Million
Brief: ODI Pharma Reports Revised Qtrly Result Per Share Amounted To SEK -0.09 (-0.05)
Brief: ODI Pharma Says Group's Net Sales For Q2 Amounted To Sek 458,620
Brief: ODI Pharma Says Group's Net Sales For Q3 Amounted To SEK 0 (SEK 1,567)
Brief: ODI Pharma Q2 Loss After Financial Items Narrows To SEK 0.8 Mln